The recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...
Read moreDespite positive outcomes in treating Alzheimer's disease, NICE cites small benefits and high costs ...
Read moreKey findings from the ABPI's latest report highlight challenges and opportunities in NICE's health t...
Read moreThe Biden administration’s recent drug price negotiations under the Inflation Reduction Act re...
Read moreThe Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...
Read moreNICE recommends gene therapy for severe beta-thalassaemia, offering hope for improved quality of lif...
Read moreThe Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreIncrease in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreNew doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi...
Read moreGermany's new Medicines Research Act allows confidential rebates for pharma companies, but recent am...
Read more